Physician profile
Mansi Raina
NPI 1730603382
$2,183.44
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $864 · 2021: $26.55 · 2022: $44.94 · 2023: $1,044 · 2024: $36.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $600 · Food and Beverage: $424 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $56.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $600.00 |
| Food and Beverage | $423.77 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $56.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $915.27 | 2019-2020 | |
| Straumann USA LLC | $831.50 | 2023-2024 | |
| Dentsply Sirona INC | $193.72 | 2023 | Cavitron, Suresmile |
| Align Technology, INC. | $82.59 | 2019-2022 | |
| Orapharma, A Division of Bausch Health US, LLC | $66.28 | 2020-2023 | Ossix Plus, Arestin |
| Tulsa Dental Products LLC | $40.82 | 2019 | |
| Philips North America LLC | $22.05 | 2020 | |
| Patterson Companies, INC. | $18.57 | 2024 | |
| Ultradent Products INC | $12.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mansi Raina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.